Stellence Life Sciences Private Limited - Company Profile

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2019.

2019 Bangalore, Karnataka, India Struck Off

Last Updated: July 21, 2025

About Stellence Life Sciences Private Limited

Stellence Life Sciences Private Limited, a struck off private limited company, was established on 31 July 2019 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24299KA2019PTC126688. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹10.00 K .

Its leadership includes Ramaprasad Jyothinagaravyasha Sriraman (Director), Chandrappa Seetharamaiah (Additional Director). Past directors included Pudhucode Radhakrishnan Kannan. It is based at Plot No.30, 1St Main Road J P Nagar, Third Phase, Bangalore, Karnataka, 560078.

Company Details

CIN/LLPIN
U24299KA2019PTC126688
Registration Number
126688
Incorporation Date
31 July 2019
Authorized Capital
₹1.50 M
Paid-Up Capital
₹10.00 K
ROC Code
Roc Bangalore
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 1.50 M as on 21-07-2025
Paid Up Capital ₹ 10.00 K as on 21-07-2025
Company Age 6 Year, 6 Months

Comprehensive Company Insights

Explore comprehensive insights into Stellence Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Stellence Life Sciences Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ramaprasad Jyothinagaravyasha Sriraman	Director	31 Jul 2019	Current
Chandrappa Seetharamaiah	Additional Director	11 Jan 2021	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	11 Jan 2021	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Stellence Life Sciences.

Enhance accessibility to Stellence Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Stellence Life Sciences?

Unlock access to Stellence Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Stellence Life Sciences?

Unlock and access historical data on people associated with Stellence Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Stellence Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stellence Life Sciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Stellence Life Sciences

Recent Activity within the Organization

Director Appointment

The activity Chandrappa Seetharamaiah was appointed as a Additional Director was appointed as a Additional Director on 11 Jan 2021 & has been associated with this company since 5 years 1 month . was completed.
11 Jan 2021
Director Appointment

Ramaprasad Jyothinagaravyasha Sriraman was appointed as a Director was appointed as a Director on 31 Jul 2019 & has been associated with this company since 6 years 6 months . was recorded as a recent event.
31 Jul 2019
Company Incorporation

Progress on Stellence Life Sciences Private Limited was registered on 31 Jul 2019 with Roc Bangalore & aged 6 years 6 months as per MCA records. was documented.
31 Jul 2019

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Stellence Life Sciences Private Limited?

The CIN of Stellence Life Sciences Private Limited is U24299KA2019PTC126688.

Where is Stellence Life Sciences Private Limited headquartered?

Stellence Life Sciences Private Limited is headquartered at Plot No.30, 1St Main Road J P Nagar, Third Phase, Bangalore, Karnataka, 560078.

When was Stellence Life Sciences Private Limited incorporated?

Stellence Life Sciences Private Limited was incorporated on 31 July 2019.

Who are the current directors of Stellence Life Sciences Private Limited?

The current directors of Stellence Life Sciences Private Limited are

What is the primary industry of Stellence Life Sciences Private Limited?

The primary industry of Stellence Life Sciences Private Limited is Pharma.

Is Stellence Life Sciences Private Limited a listed company?

Stellence Life Sciences Private Limited is unlisted.

What is the capital structure of Stellence Life Sciences Private Limited?

The authorized capital of Stellence Life Sciences Private Limited is ₹1.50 M, and the paid-up capital is ₹10.00 K .

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available